Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07249164

Dexmedetomidine Medication Records and Delirium After Coronary Artery Bypass Grafting

Sponsor: China Medical University Hospital

View on ClinicalTrials.gov

Summary

This retrospective observational study uses de-identified electronic health records from the TriNetX Global Collaborative Network. The procedure eligibility period is 1 January 2010 through 1 July 2025. The primary analysis concerns adults with a recorded qualifying coronary artery bypass grafting (CABG) procedure. Valve-coded procedures are examined in a separately constructed and separately matched exploratory population. The populations may overlap and do not constitute independent replication cohorts. Patients are classified by the presence or absence of a dexmedetomidine medication record on the calendar day before or the day of the index procedure. This definition does not confirm administration, dose or intraday timing. The primary outcome is a qualifying delirium or disorientation code during days 1-30. Nine secondary endpoints concern mortality and selected recorded complications during days 0-30; eight are inferential and the prolonged-ventilation code endpoint is descriptive. An inpatient or observation encounter during days 1-30 is described separately and is not interpreted as readmission. Same-day records cannot establish whether an outcome preceded or followed exposure. No treatment is assigned by the investigators. Analyses use permitted aggregate outputs, without identifiable or row-level participant data. The clinical definitions were revised with knowledge of earlier analyses. CABG primary and F05-only outcomes were first rerun on 5 September 2026 and were seen before a technical amendment permitting automatic propensity-score rematching for each outcome batch and unavoidable comparative calculations accompanying descriptive patient counts. The approved eligibility, exposure and outcome windows, codes, covariates, category boundaries and eight-test multiplicity family were not changed by that technical amendment. Subsequent technical refreshes and their source versions are recorded separately. Neither the original registration nor this amendment is presented as prospective registration of the original analysis.

Official title: Preceding-Day or Procedure-Day Dexmedetomidine Medication Records and Subsequent Code-Defined Delirium After CABG-Coded Procedures: A Re-analysis of a Retrospective TriNetX Cohort Study, With Exploratory Valve-Coded Analyses

Key Details

Gender

All

Age Range

18 Years - 100 Years

Study Type

OBSERVATIONAL

Enrollment

343112

Start Date

2010-01-01

Completion Date

2025-07-31

Last Updated

2026-09-11

Healthy Volunteers

No

Interventions

DRUG

Dexmedetomidine

An observed dexmedetomidine medication record (RxNorm 48937) on the calendar day before or the day of the index procedure. No drug, dose, route or regimen is assigned by the study. This entry describes the record used for exposure classification, not a study intervention.

OTHER

No dexmedetomidine medication record in the specified window

Absence of a dexmedetomidine medication record during days -1 through 0 relative to the index procedure. Other care is not assigned or standardised by the investigators. Dexmedetomidine records outside the specified window are allowed.

Locations (1)

China Medical University Hospital

Taichung, Taichung City, Taiwan